The New Money
Posts
A Personalized Cancer Vaccine Breakthrough, Swarmer's New Air Defense Stake, And Conexeu's Medical Aesthetics Ambition

A Personalized Cancer Vaccine Breakthrough, Swarmer's New Air Defense Stake, And Conexeu's Medical Aesthetics Ambition

The markets and trends that matter, made simple. Discover what’s next.

August 22, 2026

Moderna and Merck Hit Phase III Breakthrough For Personalized Cancer Vaccine

Moderna (NASDAQ: MRNA) and Merck (NYSE: MRK) publicly stated they've achieved a positive Phase III readout for their first personalized cancer vaccine. The co-developed vaccine acts as a personalized mRNA cancer therapy that is custom built from each patient’s own tumour mutations to train the immune system to attack the cancer. Shares of Moderna surged over +120% on the week.

Swarmer Takes Equity Stake In Erik Prince’s New Private Air Defense Company

Swarmer (NASDAQ: SWMR) has taken a 20% equity stake in Vectus Air Defense Systems, a newly formed private company focused on providing aerial defense for sovereign governments and critical infrastructure operators founded by Erik Prince.

Conexeu Sciences Is Making A Move Into Medical Aesthetics

Conexeu Sciences (NASDAQ: CNXU) publicly stated they are aiming to position their CXU platform for medical aesthetics and facial and body tissue restoration. The company has successfully completed their 12 month preclinical study focused on evaluating their proprietary CXU platform as a potential tissue restoration solution for medical aesthetics and the knock on effects caused by GLP-1 weight loss drugs, including both facial volume loss and skin laxity.

The New Money App Is Here

Discover markets, trends, and the world’s most exciting stocks easier than ever before with the newest version of The New Money App, now available in the App Store and Google Play.

The Sprint

Micron (NASDAQ: MU) unveiled plans to invest $10 billion into Micron Research Labs to advance memory and compute breakthroughs for artificial intelligence.
Marvell Technology (NASDAQ: MRVL) and Google (NASDAQ: GOOG) expanded their existing deal for custom silicon for Google’s TPU ecosystem. Google received warrants in the deal that would allow them to buy approximately 7% of Marvell.
Standard Nuclear (NYSE: STDN) entered into a new binding fuel supply agreement with nuclear microreactor startup Radiant Industries.
Unitree Robotics raised approximately $905 million in an IPO financing round and began trading on the Shanghai STAR Market, with shares surging over +600% in their first day of trading.
Ur-Energy (NYSE: URG) successfully made their first shipment of uranium from their Shirley Basin mine in Wyoming to their Lost Creek processing plant.
Stripe entered into a deal to acquire artificial intelligence model routing platform OpenRouter.

The Markets This Week

+154.4% | BTC Digital

+129.1% | Moderna

+118.9% | Cypherpunk Technologies

+58.3% | Hyperliquid Strategies

+55.4% | Canaan Inc.

+48.0% | Strive Inc.

+46.7% | Metaplanet

+43.7% | Upexi

+43.4% | Nakamoto

+39.6% | Tempus AI

Top Trends This Week

+45.7% | Cameron and Tyler Winklevoss

+36.9% | Memecoins

+23.3% | Hyperliquid Holders

+23.2% | a16z

+21.5% | Dan Morehead

Looking to connect? Reach out and get in touch.

New here? Join our community of 100,000+ individuals interested in uncovering the world’s most exciting early stage companies.

Disclaimer: The New Money provides background information on early stage companies from publicly available sources. The New Money provides no advice on dealing in securities, is not a financial adviser and does not pretend to be so. This message is meant for information and educational purposes only. The information contained in this email is not to be considered factual or complete. Anybody interested in obtaining financial and other information on companies mentioned is advised to get it direct from the companies, or from their own investment adviser. The New Money does not intend for this information to be used to inform an investment decision. The New Money has been compensated by some of the companies mentioned in this email for awareness campaigns, which affects our ability to be unbiased. The Principals of The New Money may buy or sell shares of the mentioned companies without further notice. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. The New Money and its principals and agents are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Always do your own research and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy or Sell securities. No representation is being made that any stock trade will or is likely to achieve profits. Comparisons made to other featured companies or past performance is not indicative of future results.